Advanced

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

Bielack, Stefan S; Smeland, Sigbjørn; Whelan, Jeremy S; Marina, Neyssa; Jovic, Gordana; Hook, Jane M; Krailo, Mark D; Gebhardt, Mark; Pápai, Zsuzsanna and Meyer, James, et al. (2015) In Journal of Clinical Oncology 33(20). p.92-2279
Abstract
EURAMOS-1, an international randomized controlled trial, investigated maintenance therapy with pegylated interferon alfa-2b (IFN-α-2b) in patients whose osteosarcoma showed good histologic response (good response) to induction chemotherapy.
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Clinical Oncology
volume
33
issue
20
pages
92 - 2279
publisher
American Society of Clinical Oncology
external identifiers
  • pmid:26033801
  • wos:000361653400008
  • scopus:84941276779
ISSN
1527-7755
DOI
10.1200/JCO.2014.60.0734
language
English
LU publication?
yes
id
d28df80f-9433-4f99-98e7-bd5b425390d9 (old id 7508515)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26033801?dopt=Abstract
date added to LUP
2015-07-05 22:53:06
date last changed
2017-11-12 03:05:45
@article{d28df80f-9433-4f99-98e7-bd5b425390d9,
  abstract     = {EURAMOS-1, an international randomized controlled trial, investigated maintenance therapy with pegylated interferon alfa-2b (IFN-α-2b) in patients whose osteosarcoma showed good histologic response (good response) to induction chemotherapy.},
  author       = {Bielack, Stefan S and Smeland, Sigbjørn and Whelan, Jeremy S and Marina, Neyssa and Jovic, Gordana and Hook, Jane M and Krailo, Mark D and Gebhardt, Mark and Pápai, Zsuzsanna and Meyer, James and Nadel, Helen and Randall, R Lor and Deffenbaugh, Claudia and Nagarajan, Rajaram and Brennan, Bernadette and Letson, G Douglas and Teot, Lisa A and Goorin, Allen and Baumhoer, Daniel and Kager, Leo and Werner, Mathias and Lau, Ching C and Sundby Hall, Kirsten and Gelderblom, Hans and Meyers, Paul and Gorlick, Richard and Windhager, Reinhard and Helmke, Knut and Eriksson, Mikael and Hoogerbrugge, Peter M and Schomberg, Paula and Tunn, Per-Ulf and Kühne, Thomas and Jürgens, Heribert and van den Berg, Henk and Böhling, Tom and Picton, Susan and Renard, Marleen and Reichardt, Peter and Gerss, Joachim and Butterfass-Bahloul, Trude and Morris, Carol and Hogendoorn, Pancras C W and Seddon, Beatrice and Calaminus, Gabriele and Michelagnoli, Maria and Dhooge, Catharina and Sydes, Matthew R and Bernstein, Mark},
  issn         = {1527-7755},
  language     = {eng},
  number       = {20},
  pages        = {92--2279},
  publisher    = {American Society of Clinical Oncology},
  series       = {Journal of Clinical Oncology},
  title        = {Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.},
  url          = {http://dx.doi.org/10.1200/JCO.2014.60.0734},
  volume       = {33},
  year         = {2015},
}